Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumabTebbutt, N.; Murphy, F.; Zannino, D.; Wilson, K.; Cummins, M.; Abdi, E.; Strickland, A.; Lowenthal, R.; Marx, G.; Karapetis, C.; Shannon, J.; Goldstein, D.; Nayagam, S.; Blum, R.; Chantrill, L.; Simes, R.; Price, T.
2011Gemcitabine and carboplatin in carcinoma of unknown primary site (CUP) in elderly patients: Analysis of a phase 2 Adelaide Cancer Trials and Education Collaborative (ACTEC) studyBishnoi, S.; Pittman, K.; Yeend, S.; Brown, M.; Koczwara, B.; Kotasek, D.; Patterson, W.; Townsend, A.; Luke, C.; Price, T.
2011South Australian clinical registry for metastatic colorectal cancerNeo, E.; Beeke, C.; Price, T.; Maddern, G.; Karapetis, C.; Luke, C.; Roder, D.; Padbury, R.
2011Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerHaller, D.; Tabernero, J.; Maroun, J.; de Braud, F.; Price, T.; Van Cutsem, E.; Hill, M.; Gilberg, F.; Rittweger, K.; Schmoll, H.
2011Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvesselsArentz, G.; Chataway, T.; Price, T.; Izwan, Z.; Hardi, G.; Cummins, A.; Hardingham, J.
2011Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyKotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T.